Status:

COMPLETED

Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer

Lead Sponsor:

Toronto Sunnybrook Regional Cancer Centre

Collaborating Sponsors:

Ontario Cancer Research Network

Ontario Clinical Oncology Group (OCOG)

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

Radiation therapy is an important part of the treatment for lung cancer when treatment intent is for cure. Radiation is a local modality of treatment, that is, it only treats the area that the radiati...

Detailed Description

Radiation therapy is an important component in the curative treatment of non-small cell lung cancer. Targeting of the gross tumor has been facilitated by the use of CT simulation allowing for more acc...

Eligibility Criteria

Inclusion

  • Surgically resectable non-small cell lung cancer
  • Companion clinical trial to OCOG PET Lung trials

Exclusion

  • Unresectable non-small cell lung cancer
  • Unable to undergo PET CT evaluation

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT00221169

Start Date

October 1 2005

End Date

January 1 2009

Last Update

February 5 2009

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Toronto Sunnybrook Regional Cancer Centre

Toronto, Ontario, Canada, M4N 3M5

2

Toronto Sunnybrook Regional Cancer Centre

Toronto, Ontario, Canada, M4N3M5

Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer | DecenTrialz